Compumedics Ltd is a medical device company specializing in the research, development, manufacture, and distribution of advanced diagnostic technologies for sleep, neurology, and cardiology applications. Headquartered in Abbotsford, Australia, the company operates globally with subsidiaries in the United States and Germany, serving markets across the Americas, Asia Pacific, Europe, and the Middle East. Compumedics Ltd is listed on the CHI-X Market Australia – Limit Venue, an alternative trading platform that provides competitive access to Australian equities. The company’s products are designed to support clinical decision-making and improve patient outcomes in specialized healthcare settings. Compumedics Ltd is recognized for its innovation in medical technology and its commitment to advancing diagnostic solutions for complex health conditions.